Acorda Therapeutics Inc ROCE
What is the ROCE of Acorda Therapeutics Inc?
The ROCE of Acorda Therapeutics Inc is 221.80%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with roce similar to Acorda Therapeutics Inc
- Cyon Exploration has ROCE of 204.94%
- Champion Gaming Inc has ROCE of 205.91%
- Cannabis Strategic Ventures has ROCE of 208.68%
- NorZinc has ROCE of 212.68%
- Echo Plc has ROCE of 215.96%
- RattanIndia Power has ROCE of 218.16%
- Acorda Therapeutics Inc has ROCE of 221.80%
- Dxi Capital Corp has ROCE of 223.25%
- Opgen Inc has ROCE of 223.61%
- Rose Hill Acquisition Corp has ROCE of 224.74%
- The Alkaline Water has ROCE of 225.00%
- Freedom Oil And Gas Ltd has ROCE of 225.06%
- Nicolas Miguet et Associes SA has ROCE of 227.31%